We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BODI icon
3676
The Beachbody Company
BODI
$74.8M
$2.77K ﹤0.01%
188
-197
-51% -$3.95K
CALT
3677
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$2.72K ﹤0.01%
149
+10
+7% +$173
KRON
3678
DELISTED
Kronos Bio
KRON
$2.71K ﹤0.01%
2,088
-4,168
-67% -$6.73K
AUTL
3679
Autolus Therapeutics
AUTL
$562M
$2.67K ﹤0.01%
1,148
-80
-7% -$228
RAIL icon
3680
FreightCar America
RAIL
$260M
$2.67K ﹤0.01%
1,001
GNFT
3681
DELISTED
Genfit
GNFT
$2.63K ﹤0.01%
803
GIFI
3682
DELISTED
Gulf Island Fabrication
GIFI
$2.62K ﹤0.01%
800
SYRS
3683
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.6K ﹤0.01%
659
CCJ icon
3684
Cameco
CCJ
$42.4B
$2.58K ﹤0.01%
65
+25
+63% +$884
LUXE
3685
LuxExperience B.V.
LUXE
$1.11B
$2.55K ﹤0.01%
750
CMMB
3686
Chemomab Therapeutics
CMMB
$14.1M
$2.54K ﹤0.01%
711
-40
-5% -$187
ADTH
3687
DELISTED
AdTheorent Holding Co
ADTH
$2.4K ﹤0.01%
1,865
-3,034
-62% -$4.17K
APEI icon
3688
American Public Education
APEI
$940M
$2.39K ﹤0.01%
481
-1,423
-75% -$7.29K
ASLN
3689
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$2.39K ﹤0.01%
162
IMCR icon
3690
Immunocore
IMCR
$1.73B
$2.39K ﹤0.01%
46
OPAD icon
3691
Offerpad Solutions
OPAD
$23.1M
$2.35K ﹤0.01%
24
-16
-40% -$1.79K
NOTV
3692
DELISTED
Inotiv
NOTV
$2.29K ﹤0.01%
745
-602
-45% -$2.75K
QH
3693
Quhuo Limited Class A Ordinary Shares
QH
$12M
$2.27K ﹤0.01%
19
HKD
3694
AMTD Digital
HKD
$534M
$2.26K ﹤0.01%
410
+160
+64% +$978
BWEN icon
3695
Broadwind
BWEN
$109M
$2.24K ﹤0.01%
700
MITT
3696
TPG Mortgage Investment Trust
MITT
$225M
$2.21K ﹤0.01%
399
CAMP
3697
DELISTED
CalAmp Corp.
CAMP
$2.19K ﹤0.01%
235
PHX
3698
DELISTED
PHX Minerals
PHX
$2.18K ﹤0.01%
600
SII
3699
Sprott
SII
$3.03B
$2.13K ﹤0.01%
70
ASMB icon
3700
Assembly Biosciences
ASMB
$529M
$2.12K ﹤0.01%
200

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.